EDX MEDICAL GROUPEDX MEDICAL GROUPEDX MEDICAL GROUP

EDX MEDICAL GROUP

No trades
See on Supercharts

EDX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
EDX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company